By integrating advanced diagnostics into patient pathways, we seek to enhance clinical decision-making, improve patient outcomes, and optimise the use of finite healthcare resources. Through a collaborative approach, this initiative explores current opportunities, promotes best practices, and facilitates cross-sector partnerships to shape the future of infection diagnostics across the UK.
Launched during the policy roundtable discussion, Optimising the Use of Diagnostics for Infection in Patient Pathways, at the UK Parliament, this initiative—led by the British Society for Antimicrobial Chemotherapy—serves as a catalyst for change.
By driving practical solutions and informed policy discussions, it aims to create lasting improvements in the integration of advanced diagnostics, ensuring more effective healthcare practices.